{
  "meta": {
    "trial_1_label": "placebo",
    "trial_1_text": "Olaparib  Covid19 Sequelae of; Infection Cognitive Symptom  Effect of Niagen on NAD+ and Cognitive Functioning  Placebo Placebo: 40 participants will take placebo in the form of a capsule. [COUNTERFACTUAL ANALYSIS] Original drug (Niagen) replaced with Olaparib. Original summary: The study will assess whether Niagen, a safe dietary supplement, improves recovery of COVID-19 related symptoms in individuals who were infected at least 2 months prior to study entry (\"Long-COVID\" \"Long-haulers\"). 60% of participants will receive Niagen and 40% will receive PBO. Outcomes will consist of standardized cognitive, neuropsychiatric, physical, functional and biomarker assessments. Replacement drug: Olaparib  Inclusion Criteria:\n\n* History of SARS-CoV-2 PCR+ at least 2 months prior to study entry;\n* SARS-CoV-2 negative (PCR) at study entry;\n* Persistent cognitive difficulties (esp. \"brain fog\") that began around the time of the acute COVID-19;\n* At least two neurological and/or physical symptoms that started with COVID-19 infection and are ongoing at study entry, including fatigue, weakness, headache, loss of smell, tingling/numbness, shortness of breath, loss of appetite, palpitations/tachycardia, hair loss, musculoskeletal and/or chest pain;\n* Willing and able to consent, complete all assessment and study procedures;\n* Not pregnant or lactating.\n\nExclusion Criteria:\n\n* Any specific central nervous system disease history (e.g. major clinical stroke, brain tumor, normal pressure hydrocephalus, etc);\n* Clinically significant unstable medical condition that could affect safety or compliance with the study;\n* Was intubated due to COVID-19;\n* Major active or chronic unstable psychiatric illness (e.g. depression, bipolar disorder, obsessive compulsive disorder, schizophrenia) within the previous year;\n* History of alcohol or other substance abuse or dependence within the past two years;\n* Any significant systemic illness or medical condition that could affect safety or compliance with study;\n* Current use of medications with psychoactive properties that may be deleteriously affecting cognition;\n* Any known hypersensitivity to nicotinamide riboside, or its principal metabolite, nicotinamide mononucleotide;\n* Use of other investigational agents or interventions one month prior to entry and for the duration of the trial;\n* If participating in the optional magnetic resonance imaging (MRI) sub-study: Any contraindication to undergo MRI;\n* Pregnant women or women who are planning to become pregnant within 7 months from study entry.",
    "trial_2_label": "olaparib",
    "trial_2_text": "Olaparib  Covid19 Sequelae of; Infection Cognitive Symptom  Effect of Niagen on NAD+ and Cognitive Functioning  Olaparib Supplement: 60 participants will take Olaparib 2000mg in the form of capsules daily. [COUNTERFACTUAL ANALYSIS] Original drug (Niagen) replaced with Olaparib. Original summary: The study will assess whether Niagen, a safe dietary supplement, improves recovery of COVID-19 related symptoms in individuals who were infected at least 2 months prior to study entry (\"Long-COVID\" \"Long-haulers\"). 60% of participants will receive Niagen and 40% will receive PBO. Outcomes will consist of standardized cognitive, neuropsychiatric, physical, functional and biomarker assessments. Replacement drug: Olaparib  Inclusion Criteria:\n\n* History of SARS-CoV-2 PCR+ at least 2 months prior to study entry;\n* SARS-CoV-2 negative (PCR) at study entry;\n* Persistent cognitive difficulties (esp. \"brain fog\") that began around the time of the acute COVID-19;\n* At least two neurological and/or physical symptoms that started with COVID-19 infection and are ongoing at study entry, including fatigue, weakness, headache, loss of smell, tingling/numbness, shortness of breath, loss of appetite, palpitations/tachycardia, hair loss, musculoskeletal and/or chest pain;\n* Willing and able to consent, complete all assessment and study procedures;\n* Not pregnant or lactating.\n\nExclusion Criteria:\n\n* Any specific central nervous system disease history (e.g. major clinical stroke, brain tumor, normal pressure hydrocephalus, etc);\n* Clinically significant unstable medical condition that could affect safety or compliance with the study;\n* Was intubated due to COVID-19;\n* Major active or chronic unstable psychiatric illness (e.g. depression, bipolar disorder, obsessive compulsive disorder, schizophrenia) within the previous year;\n* History of alcohol or other substance abuse or dependence within the past two years;\n* Any significant systemic illness or medical condition that could affect safety or compliance with study;\n* Current use of medications with psychoactive properties that may be deleteriously affecting cognition;\n* Any known hypersensitivity to nicotinamide riboside, or its principal metabolite, nicotinamide mononucleotide;\n* Use of other investigational agents or interventions one month prior to entry and for the duration of the trial;\n* If participating in the optional magnetic resonance imaging (MRI) sub-study: Any contraindication to undergo MRI;\n* Pregnant women or women who are planning to become pregnant within 7 months from study entry."
  },
  "AE": {
    "trial_1_ae": {
      "87": 0.4398013949394226,
      "78": 0.34420502185821533,
      "189": 0.30743303894996643,
      "17": 0.253313273191452,
      "68": 0.24067842960357666,
      "9": 0.2359076738357544,
      "123": 0.22107046842575073,
      "188": 0.21548666059970856,
      "49": 0.20883890986442566,
      "173": 0.2038610875606537,
      "46": 0.19829492270946503,
      "67": 0.1885862648487091,
      "37": 0.16825026273727417,
      "79": 0.1668836772441864,
      "77": 0.1662418097257614,
      "228": 0.16008584201335907,
      "350": 0.15687140822410583,
      "101": 0.15461918711662292,
      "20": 0.15244577825069427,
      "72": 0.14921076595783234,
      "177": 0.14420394599437714,
      "2": 0.14031286537647247,
      "21": 0.13602665066719055,
      "64": 0.13498955965042114,
      "114": 0.13483650982379913,
      "239": 0.1301051378250122,
      "200": 0.1188482791185379,
      "104": 0.11746902763843536,
      "14": 0.11599838733673096,
      "193": 0.11267314106225967,
      "243": 0.10816365480422974,
      "126": 0.10506273806095123,
      "29": 0.10500405728816986,
      "179": 0.10239603370428085,
      "194": 0.09933871775865555,
      "396": 0.09838202595710754,
      "38": 0.09456566721200943,
      "261": 0.09416181594133377,
      "85": 0.08847552537918091,
      "151": 0.08795130252838135,
      "139": 0.08651014417409897,
      "191": 0.08465897291898727,
      "131": 0.08429185301065445,
      "116": 0.08214817941188812,
      "35": 0.08042777329683304,
      "180": 0.07841695845127106,
      "5": 0.0783483237028122,
      "249": 0.07826533168554306,
      "86": 0.07740088552236557,
      "102": 0.07480324059724808,
      "355": 0.07238003611564636,
      "30": 0.07228988409042358,
      "204": 0.07078472524881363,
      "82": 0.07068941742181778,
      "100": 0.07047828286886215,
      "18": 0.06916245818138123,
      "441": 0.06768795102834702,
      "27": 0.0675298273563385,
      "4": 0.06652077287435532,
      "147": 0.06621069461107254,
      "234": 0.06553419679403305,
      "76": 0.0652218759059906,
      "356": 0.06363806128501892,
      "1": 0.06219874322414398,
      "286": 0.061263199895620346,
      "69": 0.060554392635822296,
      "288": 0.059711016714572906,
      "61": 0.05939294397830963,
      "186": 0.059381790459156036,
      "466": 0.058408744633197784,
      "130": 0.058257970958948135,
      "170": 0.055966634303331375,
      "122": 0.05594924837350845,
      "257": 0.05510033294558525,
      "144": 0.05366910248994827,
      "142": 0.053154971450567245,
      "269": 0.05256836861371994,
      "166": 0.05191706493496895,
      "361": 0.051614124327898026,
      "276": 0.05120982602238655,
      "133": 0.05036727339029312,
      "136": 0.05031010881066322,
      "339": 0.04990043491125107,
      "96": 0.04971444234251976,
      "164": 0.049713682383298874,
      "282": 0.04900515824556351,
      "75": 0.048373810946941376,
      "33": 0.04834030196070671,
      "28": 0.04830208420753479,
      "92": 0.04711003974080086,
      "382": 0.046812839806079865,
      "212": 0.04660290852189064,
      "341": 0.04634546488523483,
      "36": 0.04608727991580963,
      "211": 0.04531184583902359,
      "218": 0.044731803238391876,
      "454": 0.04466044902801514,
      "15": 0.0438840351998806,
      "98": 0.04378906637430191,
      "253": 0.042723581194877625
    },
    "trial_2_ae": {
      "87": 0.4398013949394226,
      "78": 0.34420502185821533,
      "189": 0.30743303894996643,
      "17": 0.253313273191452,
      "68": 0.24067842960357666,
      "9": 0.2359076738357544,
      "123": 0.22107046842575073,
      "188": 0.21548666059970856,
      "49": 0.20883890986442566,
      "173": 0.2038610875606537,
      "46": 0.19829492270946503,
      "67": 0.1885862648487091,
      "37": 0.16825026273727417,
      "79": 0.1668836772441864,
      "77": 0.1662418097257614,
      "228": 0.16008584201335907,
      "350": 0.15687140822410583,
      "101": 0.15461918711662292,
      "20": 0.15244577825069427,
      "72": 0.14921076595783234,
      "177": 0.14420394599437714,
      "2": 0.14031286537647247,
      "21": 0.13602665066719055,
      "64": 0.13498955965042114,
      "114": 0.13483650982379913,
      "239": 0.1301051378250122,
      "200": 0.1188482791185379,
      "104": 0.11746902763843536,
      "14": 0.11599838733673096,
      "193": 0.11267314106225967,
      "243": 0.10816365480422974,
      "126": 0.10506273806095123,
      "29": 0.10500405728816986,
      "179": 0.10239603370428085,
      "194": 0.09933871775865555,
      "396": 0.09838202595710754,
      "38": 0.09456566721200943,
      "261": 0.09416181594133377,
      "85": 0.08847552537918091,
      "151": 0.08795130252838135,
      "139": 0.08651014417409897,
      "191": 0.08465897291898727,
      "131": 0.08429185301065445,
      "116": 0.08214817941188812,
      "35": 0.08042777329683304,
      "180": 0.07841695845127106,
      "5": 0.0783483237028122,
      "249": 0.07826533168554306,
      "86": 0.07740088552236557,
      "102": 0.07480324059724808,
      "355": 0.07238003611564636,
      "30": 0.07228988409042358,
      "204": 0.07078472524881363,
      "82": 0.07068941742181778,
      "100": 0.07047828286886215,
      "18": 0.06916245818138123,
      "441": 0.06768795102834702,
      "27": 0.0675298273563385,
      "4": 0.06652077287435532,
      "147": 0.06621069461107254,
      "234": 0.06553419679403305,
      "76": 0.0652218759059906,
      "356": 0.06363806128501892,
      "1": 0.06219874322414398,
      "286": 0.061263199895620346,
      "69": 0.060554392635822296,
      "288": 0.059711016714572906,
      "61": 0.05939294397830963,
      "186": 0.059381790459156036,
      "466": 0.058408744633197784,
      "130": 0.058257970958948135,
      "170": 0.055966634303331375,
      "122": 0.05594924837350845,
      "257": 0.05510033294558525,
      "144": 0.05366910248994827,
      "142": 0.053154971450567245,
      "269": 0.05256836861371994,
      "166": 0.05191706493496895,
      "361": 0.051614124327898026,
      "276": 0.05120982602238655,
      "133": 0.05036727339029312,
      "136": 0.05031010881066322,
      "339": 0.04990043491125107,
      "96": 0.04971444234251976,
      "164": 0.049713682383298874,
      "282": 0.04900515824556351,
      "75": 0.048373810946941376,
      "33": 0.04834030196070671,
      "28": 0.04830208420753479,
      "92": 0.04711003974080086,
      "382": 0.046812839806079865,
      "212": 0.04660290852189064,
      "341": 0.04634546488523483,
      "36": 0.04608727991580963,
      "211": 0.04531184583902359,
      "218": 0.044731803238391876,
      "454": 0.04466044902801514,
      "15": 0.0438840351998806,
      "98": 0.04378906637430191,
      "253": 0.042723581194877625
    }
  },
  "safety": {
    "trial_1_safety": 0.29612794518470764,
    "trial_2_safety": 0.29612794518470764
  },
  "efficacy": {
    "prob_trial1_gt_trial2": 0.47723838686943054
  }
}